Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01605838
Other study ID # ABM-TBI-0001
Secondary ID W81XWH - 10 - C
Status Withdrawn
Phase N/A
First received May 22, 2012
Last updated January 12, 2015
Start date August 2012
Est. completion date May 2014

Study information

Verified date January 2015
Source Advanced Brain Monitoring, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

BACKGROUND: The brain is very sensitive to both excessive and insufficient flow of blood. Cerebral blood flow (CBF) is normally auto-regulated by the blood vessels in the brain, but this protective mechanism is often disturbed after a traumatic brain injury (TBI). Impairment or loss of the CBF autoregulation makes the brain vulnerable to oscillations of either arterial blood pressure (ABP) or intracranial pressure (ICP). The ideal management of TBI patients, therefore, involves continuous measurement and management of the cerebral perfusion pressure (CPP = ABP - ICP) but the measurement of CPP is currently possible only with specialized equipment and expertise that is not available in all institutions. The investigators have converted a no-longer used system that continuously monitors CBF autoregulation using rheoencephalography (REG) technology into a modern, small, battery-powered, low-cost monitor (aka BM-1) that acquires the REG signals using only noninvasive electrodes placed on the skin/scalp. REG data can then be used to calculate the optimal CPP to maintain in each individual patient. BM-1 is also capable of monitoring electroencephalography (EEG) and impedance plethysmography (IPG), which can, respectively, be used to measure brain electrical activity and changes in peripheral blood flow caused by blood pressure changes.

OBJECTIVES: The primary objectives are to (Obj. 1) demonstrate that REG acquired noninvasively is equal to the well-established but invasive method using intracranial pressure (ICP) monitoring, (Obj. 2) retrospectively test the idea that TBI patients have a less favorable outcome if their CPP were found less optimal using the REG data, and (Obj. 3) determine if noninvasive IPG or the PPG finger sensor monitoring (used to measure heart rate in doctor's offices) can replace the invasive monitoring of arterial blood pressure (ABP).

METHODOLOGY: This is an observational study with retrospective data analysis. 20 adult patients (18-65 yrs) with acute TBI, who meet the inclusion/exclusion criteria, will be enrolled on a first-come-first-enroll basis. The enrolled patients will have the REG, EEG and IPG signals monitored for the duration of ICU stay or 15 days, whichever is shorter. Standard neurological assessment will be made at the patient's discharge from the ICU and at 3 months after injury. The study is expected to end June 2013.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date May 2014
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Clinical diagnosis of acute moderate or severe TBI

- Hospitalization within 12 hours from the injury

- Intraarterial catheterization and intracranial pressure (ICP) monitoring instantiated within 72 hours from the injury

Exclusion Criteria:

- Earlier head injuries, stroke, space-occupying intracranial lesions, meningitis, or cerebral vasculopathies

- Concomitant severe injuries of the chest, abdomen, pelvis, extremities or spine

- Concurrent terminal illness with a life expectancy of less than 6 months

- Unlikely to survive the next 48 hours after enrollment

- Implanted cardiac pacemaker, cardiac converter/defibrillator, or other electrical stimulator

- Pregnancy

- Patient is a prisoner or on a probation

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States LA County + USC Medical Center Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
Advanced Brain Monitoring, Inc. University of Southern California

Country where clinical trial is conducted

United States, 

References & Publications (12)

Bodo M, Pearce FJ, Armonda RA. Cerebrovascular reactivity: rat studies in rheoencephalography. Physiol Meas. 2004 Dec;25(6):1371-84. — View Citation

Bodo M, Pearce FJ, Baranyi L, Armonda RA. Changes in the intracranial rheoencephalogram at lower limit of cerebral blood flow autoregulation. Physiol Meas. 2005 Apr;26(2):S1-17. Epub 2005 Mar 29. — View Citation

Bodo M, Pearce FJ, Montgomery LD, Rosenthal M, Kubinyi G, Thuroczy G, Braisted J, Forcino D, Morrissette C, Nagy I. Measurement of brain electrical impedance: animal studies in rheoencephalography. Aviat Space Environ Med. 2003 May;74(5):506-11. — View Citation

Bodo M. Studies in rheoencephalography . Journal of Electrical Bioimpedance 2010; 1: 18 - 40.

Brady KM, Shaffner DH, Lee JK, Easley RB, Smielewski P, Czosnyka M, Jallo GI, Guerguerian AM. Continuous monitoring of cerebrovascular pressure reactivity after traumatic brain injury in children. Pediatrics. 2009 Dec;124(6):e1205-12. doi: 10.1542/peds.2009-0550. — View Citation

Czosnyka M, Smielewski P, Kirkpatrick P, Menon DK, Pickard JD. Monitoring of cerebral autoregulation in head-injured patients. Stroke. 1996 Oct;27(10):1829-34. — View Citation

Lam JM, Hsiang JN, Poon WS. Monitoring of autoregulation using laser Doppler flowmetry in patients with head injury. J Neurosurg. 1997 Mar;86(3):438-45. — View Citation

Lang EW, Chesnut RM. A bedside method for investigating the integrity and critical thresholds of cerebral pressure autoregulation in severe traumatic brain injury patients. Br J Neurosurg. 2000 Apr;14(2):117-26. — View Citation

Lang EW, Mehdorn HM, Dorsch NW, Czosnyka M. Continuous monitoring of cerebrovascular autoregulation: a validation study. J Neurol Neurosurg Psychiatry. 2002 May;72(5):583-6. — View Citation

Overgaard J, Tweed WA. Cerebral circulation after head injury. 1. Cerebral blood flow and its regulation after closed head injury with emphasis on clinical correlations. J Neurosurg. 1974 Nov;41(5):531-41. — View Citation

Schmidt B, Czosnyka M, Raabe A, Yahya H, Schwarze JJ, Sackerer D, Sander D, Klingelhöfer J. Adaptive noninvasive assessment of intracranial pressure and cerebral autoregulation. Stroke. 2003 Jan;34(1):84-9. — View Citation

Steiner LA, Czosnyka M, Piechnik SK, Smielewski P, Chatfield D, Menon DK, Pickard JD. Continuous monitoring of cerebrovascular pressure reactivity allows determination of optimal cerebral perfusion pressure in patients with traumatic brain injury. Crit Care Med. 2002 Apr;30(4):733-8. — View Citation

* Note: There are 12 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Extended Glasgow Outcome Scale (GOSE) 3 months post-injury No
Secondary Neurobehavioral Symptom Inventory (NSI) 3 months post-injury No
Secondary Rappaport Disability Rating Scale (DSR) Note regarding the time frame: based on the USC patient database for 2010 and 2011, patients may be discharged from the ICU anywhere between 4 days to 4 weeks; 50% of them will spend 10 +/- 3 days in the ICU. At discharge from intensive care unit; on average, 10 days post-injury No
Secondary Katz Index of Independence in Activities of Daily Living (KI-ADL) 3 months post-injury No
See also
  Status Clinical Trial Phase
Completed NCT02878577 - Monitoring the Alterations That Occur in the Brain Following Traumatic Brain Injury
Active, not recruiting NCT02918994 - LearningRx Cognitive Training for TBI N/A
Completed NCT02524067 - Modified Environment for Agitation in Patients With TBI N/A
Completed NCT01760785 - Valproate for Mood Swings and Alcohol Use Following Head Injury N/A
Recruiting NCT05033444 - A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers Phase 1
Not yet recruiting NCT04003285 - Allopregnanolone in Chronic Complex Traumatic Brain Injury Phase 2
Completed NCT01750268 - Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI Phase 4
Recruiting NCT01512524 - Hormonal Deficiency in the Quality of Life of Patients With Traumatic Brain Injury N/A
Completed NCT04796207 - The Effects of Fish Oil Supplementation on the Brain Health of Collegiate Football Athletes N/A
Completed NCT02657135 - Targeted Evaluation, Action, & Monitoring of Traumatic Brain Injury N/A
Completed NCT01956136 - Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury N/A
Withdrawn NCT02356861 - LED Light Therapy to Improve Cognitive & Psychosocial Function in TBI-PTSD Veterans N/A
Recruiting NCT04930146 - Functional Recovery Effect of Bloodletting Puncture at Jing-well Points on Acute Brain Injury Patients N/A
Not yet recruiting NCT05675423 - Imaging Characterization of the Biomechanical Coupling of Brain and Skull
Withdrawn NCT01891383 - Clinical Characteristics of Dementias That Occur Remotely After Traumatic Brain Injury in Retired Military Personnel
Completed NCT02764983 - Occupational Therapy Driving Intervention for Returning Combat Veterans. N/A
Withdrawn NCT01779427 - Attention Intervention Management N/A
Completed NCT01118195 - Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans N/A
Completed NCT01547780 - Translocator Protein and Inflammation After Traumatic Brain Injury Phase 1/Phase 2
Recruiting NCT03874208 - Prediction for Coma Recovery With Comaweb N/A